Healthcare

Lower Back Pain Market Shows Strong Growth by 2026| BioWave Corporation, Koninklijke Philips N.V., Stayble Therapeutics AB, Axsome Therapeutics, Inc., Mesoblast Ltd, ALLERGAN

A new research report is added in Data Bridge Market Research database of 350 pages, titled as “Global Lower Back Pain Market – Industry Trends and Forecast to 2026” with detailed analysis, competitive landscape, forecast and strategies. The study covers geographic analysis and important players/vendors such as Pfizer Inc., Johnson & Johnson Services, Inc., Sanofi, Endo Pharmaceuticals Inc., Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd., Vertebral Technologies, Inc., Medtronic, etc.

Global lower back pain market is expected to register a substantial CAGR of 5.2% in the forecast period of 2019-2026. This rise in market value can be attributed to the increased development of novel drugs for lower back pain and increasing cases of chronic lower back pain in various regions globally.

Request a Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lower-back-pain-market

Global Lower Back Pain Market By Type of Disease (Acute, Sub-Acute, Chronic), Type (Diagnosis, Treatment), End User (Hospitals, Orthopaedic Clinics, Ambulatory Surgery Centres, Others), Distribution Channel (Direct, Retail), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

Low back pain (LBP) is a type of muscle tension, musculoskeletal pain, or rigidity located above the gluteal sulcus and below the bottom edge of rib cage. The low back pain can be of three types: acute, sub-acute and chronic. Numerous disorders and diseases which disturb the lumbar region of the spine can cause this type of pain. According to the National Institute of Neurological Disorders and Stroke 2019 report approximately 80 percent adults experience this type of low back pain at some point of time in their lifetimes. According to the American Chiropractic Association report, America spends approximately USD 50,000 million in health care for the low-back pain each year.

Market Drivers:

  • Inactive lifestyle is expected to drive the growth of the market
  • Rising nerve cases can act as a market driver
  • Rising use of emerging antidepressants is expected to boost the growth of this market
  • Increasing geriatric population also enhances the market growth

Market Restraints:

  • Unfavourable results of medications is expected to restrict the growth of the market
  • Stringent regulatory policies, is restricting the overall adoption of these meters
  • Unavailability of the medication is expected to restrict the growth of the market

Get TOC for Full Analysis of Report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-lower-back-pain-market

Segmentation: Global Lower Back Pain Market

By Type of Disease

  • Acute
  • Sub-Acute
  • Chronic

By Type

  • Diagnosis
  • Treatment
    • Surgery
    • Medications
      • Analgesic Medications
      • Nonsteroidal Anti-Inflammatory Drugs
      • Anticonvulsants
      • Antidepressants
      • Others

By End-User

  • Hospitals
  • Orthopaedic Clinics
  • Ambulatory Surgery Centres
  • Others

By Distribution Channel

  • Direct
  • Retail

By Geography

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • UK.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Rest of South America
  • Middle East and Africa
    • South Africa
    • Rest of Middle East and Africa

Key Developments in the Market:

  • In July 2018, Pfizer Inc. and Eli Lilly and Company received FDA approval for its tanezumab which can be used in the treatment of chronic low back pain (CLBP) and chronic pain of osteoarthritis (OA) patients. Tanezumab is a new humanized monoclonal antibody. This drug binds and inhibits nerve growth factor (NGF). This is the first NGF inhibitor which has received the Fast Track designation for serious conditions
  • In July 2016, Relievant Medsystems, Inc. received FDA approval for its Intracept intraosseous nerve ablation system. This device is specially designed to treat chronic lower back pain. This product approval has created a milestone for the company

Competitive Analysis

Global lower back pain market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of lower back pain market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Few of the major competitors currently working in the global lower back pain market are Pfizer Inc., Johnson & Johnson Services, Inc., Sanofi, Endo Pharmaceuticals Inc., Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd., Vertebral Technologies, Inc., Medtronic, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Stayble Therapeutics AB, Axsome Therapeutics, Inc. , Mesoblast Ltd, ALLERGAN, Frontier Biotechnologies Inc., Astellas Pharma Inc., SpineThera, Inc., CELGENE CORPORATION, Teva Pharmaceutical Industries Ltd. among others.

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Get 25% Impressive Discount on this Report @ https://www.databridgemarketresearch.com/request-a-discount/global-lower-back-pain-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Report Rating
Close